Psychedelic Spotlight Podcast

131 Folgen

1. Real Estate and Psychedelic-Assisted Therapy with Ty Zakovich, Daniel Carcillo, and Cody Shandraw

   Vom: 12.1.2023
2. Discussing the Lack of Diversity in the Psychedelics Space with Jennifer Montjoy

   Vom: 11.1.2023
3. Learning About Moms on Mushrooms with Tracey Tee

   Vom: 4.1.2023
4. Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier

   Vom: 22.12.2022
5. The Awakening of Consciousness Conference with Paul Karasik

   Vom: 21.9.2022
6. Psychedelics Aiding Recovery with Arrowyn Ambrose

   Vom: 14.9.2022
7. Journalling for Psychedelic Integration with Jenalle Dion, Wakeful Travel

   Vom: 27.7.2022
8. Functional Fungi and Microdosing for Optimal Wellbeing with Alli Schaper, Into The Multiverse

   Vom: 20.7.2022
9. Medical Applications of Ketamine & Common Misconceptions with Christi Myers, Flow Integrative

   Vom: 29.6.2022
10. Psilocybin as an Agent for Human and Cultural Development with Jahan Khamsehzadeh Ph.D.

    Vom: 22.6.2022
11. Examining Ketamine-Assisted Psychotherapy with Myriam Barthes, Journey Clinical

    Vom: 15.6.2022
12. Consolidating Plant Medicine, Permaculture and Indigenous Wisdom With Colette Condorcita, Decriminalize Nature Philadelphia

    Vom: 8.6.2022
13. Oregon's Psilocybin Services Policy with Sam Chapman

    Vom: 12.5.2022
14. Benzinga Psychedelic Capital Conference Recap with MAPS, Wesana, Felicity Pharma and Irwin Naturals

    Vom: 4.5.2022
15. Exploring Integrative Therapy and Altered States of Consciousness with Lana Rados, Intronaut

    Vom: 6.4.2022
16. Psychedelics, Pharmaceutical Medicine, & the Soul with Dr. Erica Zelfand

    Vom: 24.2.2022
17. Defunding the DEA with Joe Moore, Psychedelics Today

    Vom: 17.2.2022
18. 5-MeO-DMT: Throwing the Grenade into the Lake of Your Subconscious Mind with Tandava Retreats

    Vom: 4.2.2022
19. Rick Doblin on Sending the Soviets MDMA, Treating PTSD with Psychedelics and What the Future Holds

    Vom: 26.1.2022
20. Meet Mindset Pharma, a Leader in the Race to Develop Next-Gen Psychedelic Compounds

    Vom: 7.1.2022